Adriana Rossi

1.8k citations
94 papers · 745 indexed · h-index 15
Topics
Multiple Myeloma Research and Treatments (58 papers)CAR-T cell therapy research (20 papers)Protein Degradation and Inhibitors (19 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood

In The Last Decade

Adriana Rossi

80 papers receiving 731 citations

Peers

Adriana Rossi
Comparison fields: 5 of 70
  • Hematology 421
  • Oncology 394
  • Molecular Biology 317
  • Surgery 89
  • Immunology 83
Replace Divaya Bhutani with:
Divaya Bhutani United States
Sascha A. Tuchman United States
Howard R. Terebelo United States
Ivetta Danylesko Israel
Mario R. Velasco United States
Akio Kohno Japan
M V Relling United States
Peter Bojko Germany
Kyu Bo Lee South Korea
Shin‐ichiro Mori Japan
Adriana Rossi relative to Divaya Bhutani United States Divaya Bhutani's profile →
Citations per field
00.5×2.8×
Divaya Bhutani · 1×
Citations per year

Countries citing papers authored by Adriana Rossi

Since Specialization
Citations

This map shows the geographic impact of Adriana Rossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adriana Rossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adriana Rossi more than expected).

Fields of papers citing papers by Adriana Rossi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adriana Rossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adriana Rossi. The network helps show where Adriana Rossi may publish in the future.

Co-authorship network of co-authors of Adriana Rossi

This figure shows the co-authorship network connecting the top 25 collaborators of Adriana Rossi. A scholar is included among the top collaborators of Adriana Rossi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adriana Rossi. Adriana Rossi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 0
4 0
5 0
6 1
7 0
8 2
9 0
10 56
11 35
12 1
13 1
14 18
15 17
16 0
17 6
18 1
19 4
20 21

About Adriana Rossi

Adriana Rossi is a scholar working on Hematology, Oncology and Genetics, having authored 94 papers that have together received 745 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (58 papers), CAR-T cell therapy research (20 papers) and Protein Degradation and Inhibitors (19 papers). The work is most often cited by research in Hematology (421 citations), Oncology (394 citations) and Transplantation (23 citations). Adriana Rossi has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Rubén Niesvizky, Roger Pearse, Tomer M. Mark, Morton Coleman, David Jayabalan, W. Robert Morrow, Jeffery A. Towbin, Karen Pekle, Robert E. Shaddy and Juan Alejos. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026